Related Experiment Video

Updated: May 6, 2026

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles
09:56

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Published on: August 2, 2016

14.2K

Particle carriers for combating multidrug-resistant cancer

Yan Yan1, Mattias Björnmalm, Frank Caruso

  • 1Department of Chemical and Biomolecular Engineering, The University of Melbourne , Victoria 3010, Australia.

ACS Nano
|November 13, 2013
PubMed

Insights

Particle carriers can help overcome multidrug resistance (MDR) in cancer by targeting tumors and delivering multiple drugs. This approach offers new strategies for treating resistant tumors and improving patient outcomes.

Area of Science:

  • Oncology
  • Nanotechnology
  • Drug Delivery

Background:

  • Multidrug resistance (MDR) is a major cause of cancer treatment failure.
  • Tumor heterogeneity complicates treatment by contributing to drug resistance.
  • Particle carriers offer a promising strategy to overcome these challenges.

Purpose of the Study:

  • To introduce mechanisms of MDR and tumor heterogeneity in cancer.
  • To highlight advances in particle-based codelivery of therapeutics for resistant tumors.
  • To discuss future directions for particle-based cancer therapies.

Main Methods:

  • Review of current literature on MDR mechanisms.
  • Analysis of tumor heterogeneity's role in drug resistance.
  • Examination of recent developments in particle carrier design for codelivery.

Main Results:

  • Particle carriers can target tumors and deliver multiple therapeutic agents.
  • Codelivery strategies show potential for overcoming MDR.
  • Advances in particle design are enabling new treatment approaches.

Conclusions:

  • Particle-based codelivery offers a promising avenue for treating multidrug-resistant cancers.
  • Further understanding of tumor biology is crucial for developing improved particle therapies.
  • Nanoparticle-based approaches hold significant potential for advancing cancer treatment.

More Related Videos

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice08:57

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

Published on: October 5, 2017

9.9K
Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier07:53

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Published on: April 26, 2016

10.2K

Related Concept Videos

Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
165
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.5K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.7K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
167